Shooting for the Stars with Astrocyte Pharmaceuticals
Description
With over 1.5 million people suffering traumatic brain
injuries a year, 80,000 stroke victims, and millions of concussions, the impact that brain impairment has on society is not to be ignored. We spoke with William Korinek of Astrocyte Pharmaceuticals, who is developing neuroprotein therapies for these conditions.
Disclaimer
The information contained in this website and podcast are
purely informational and not considered investment recommendations. Tim Dougherty’s participation in Biotech Insights is separate and apart from his role as an investment advisor representative. Nothing contained herein may be
construed as a recommendation or endorsement of any of the companies discussed.
Tim Dougherty has no financial affiliation with any of the companies mentioned in this communication. Tim Dougherty makes no representation that the information conveyed in this material is accurate and is under no obligation to
update this information as changes occur.
United States
